TickerFacts.

XBiotech Inc. (XBIT): Cost of Revenue

Annual figures by period end, from SEC filings.

Older than the company's other figures. The latest Cost of Revenue is for the year ended 2023-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.

$0
Year ended 2023-12-31
$34.55M2018-12-31: $02019-12-31: $02020-12-31: $34.55M2021-12-31: $5.82M2022-12-31: $651.0K2023-12-31: $0$0
2018-12-31 Cost of Revenue (USD) 2023-12-31
Period endedCost of RevenueChange YoYSource filing
2023-12-31$0-100.0%2024-03-15, From 2023-01-01
2022-12-31$651.0K-88.8%2024-03-15, From 2022-01-01
2021-12-31$5.82M-83.2%2023-03-15, From 2021-01-01
2020-12-31$34.55Mn/a2022-03-15, From 2020-01-01
2019-12-31$0n/a2022-03-15, From 2019-01-01
2018-12-31$0n/a2021-03-16, From 2018-01-01